When was SARomics Biostructures founded?

SARomics Biostructures was founded in 2006 and raised its 1st funding round 6 years after it was founded.

Where is SARomics Biostructures located?

SARomics Biostructures is headquartered in Lund, Sweden.

Who is the current CEO of SARomics Biostructures?

Bjorn Walse of SARomics Biostructures.

How many employees does SARomics Biostructures have?

As of Jul 01, 2024, the latest employee count at SARomics Biostructures is 23.

Is SARomics Biostructures a funded company?

SARomics Biostructures is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 18, 2012.

When was the latest funding round of SARomics Biostructures?

SARomics Biostructures' latest funding was a $***** Grant (prize money) round on Sep 01, 2017, with participation from 1 investor.

Where does SARomics Biostructures rank among its competitors?

SARomics Biostructures ranks 6th amongst 25 active competitors, of which 6 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was NanoImaging Services, which secured $12.2M in Sep, 2024.

Who are the top competitors of SARomics Biostructures?

SARomics Biostructures' top competitors include NanoImaging Services, Syrrx and Beryllium. Among them, NanoImaging Services secured the most recent funding round in September, 2024.

SARomics Biostructures - 2026 Company Profile, Team, Funding & Competitors

Company Details

SARomics Biostructures is a protein crystallization, protein crystallography, and structure-based drug design CRO. The platform focus on state-of-the-art industry-leading technologies for high-throughput protein crystallization and structure determination, computational chemistry, and fragment-based screening. SARomics structural biology platform and expertise in structure-based drug design are applied to a number of early-stage drug discovery projects as well as in fee for service projects for clients. The company's extensive portfolio of FastLane off-the-shelf protein structures, which include kinases, phosphatases, epigenetic targets, and many other proteins enables faster project execution substantially accelerating the drug discovery process.

Website: www.saromics.com/
Social
Email ID: *****@saromics.com

Key Metrics

Founded Year

2006

Location

Lund, Sweden

Stage

Seed

Latest Funding Round

Grant (prize money), Sep 01, 2017, $*****

Investors

European Investment Fund & 7 more

Ranked

6^th among 25 active competitors

Employee Count

23 as on Jul 01, 2024

Similar Companies

NanoImaging Services & 27 more

View SARomics Biostructures' full profile

SARomics Biostructures has raised funding over 6 rounds. Its first funding round was on Oct 18, 2012. Its latest funding round was a Grant (prize money) round on Sep 01, 2017 for $*****. 1 investor participated in its latest round. SARomics Biostructures has 8 institutional investors.

Here is the list of recent funding rounds of SARomics Biostructures:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 01, 2017	3954953	Grant (prize money)	2877724	6301638	7419557	5482242
Jan 09, 2017	3179385	Grant (prize money)	9438565	2493871	4896584	Europa
Apr 01, 2016	6917063	Grant (prize money)	3507362	2739451	5555730	Europa

Access funding benchmarks and valuations. Sign up today!

View details of SARomics Biostructures's funding rounds and investors

The founders of SARomics Biostructures are Bjorn Walse, Bo Svensson, Salam Al-Karadaghi and Derek Logan.

Here are the details of SARomics Biostructures' key team members:

Bjorn Walse: Founder & CEO of SARomics Biostructures.
Contact Info: 1 email address
Bo Svensson: Co-Founder & Director of SARomics Biostructures.
Salam Al-Karadaghi: Co-Founder & Director of SARomics Biostructures.
Contact Info: 1 email address
Derek Logan: Co-Founder & CSO of SARomics Biostructures.
Contact Info: 1 email address

View details of SARomics Biostructures's Founder profiles and Board Members

SARomics Biostructures' employee count trend

SARomics Biostructures has 23 employees as of Jul 24. Here is SARomics Biostructures's employee count trend over the years:

Employee count trend for SARomics Biostructures

Uncover SARomics Biostructures' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SARomics Biostructures include NanoImaging Services, Syrrx and Beryllium. Here is the list of Top 10 competitors of SARomics Biostructures, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NanoImaging Services 2007, San Diego (United States), Series A	Provider of cryo-electron microscopy, protein production, and nanoparticle characterization services	$13.7M	merckcapitalventures.com, Ampersand Capital ... & 3 others	59/100
2nd	Syrrx 1999, San Diego (United States), Acquired	Provider of drug targets research and clinical trial services	$79M	Bay City Capital, Versant Ventures & 9 others	50/100
3rd	Beryllium 1999, Bedford (United Kingdom), Acquired	Boutique service provider offering a range of solutions for drug discovery	$11.5M	UCB, Gemini & 1 others	48/100
4th	High Q Technologies 2013, Waterloo (Canada), Seed	Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis	$10.2M	Government of Canada	44/100
5th	Gemseki 2017, Tokyo (Japan), Unfunded	Provider of drug discovery services	-	-	40/100
6th	SARomics Biostructures 2006, Lund (Sweden), Seed	Provider of services for protein crystallography and structure-based drug design	-	European Investment Fund, Innovationsbron ... & 6 others	35/100
7th	Shamrock Structures 2003, Woodridge (United States), Series A	Accelerating structure-based drug discovery through protein crystallography, medicinal chemistry, and cell biology	-	HHS, Flavin Ventures	31/100
8th	Crelux 2005, Planegg (Germany), Acquired	X-ray crystallography, fragment based drug discovery and protein delivery.	-	Europa	30/100
9th	Clinical Edge 2004, Milwaukee (United States), Acquired	CRO focused on providing drug research and development services to biology	-	-	25/100
10th	Creative Biostructure 2001, New York City (United States), Unfunded	Provider of structural biology and membrane protein services for pharma industries	-	-	23/100